With the Cancer Institute AP-HP. Nord – Université Paris Cité, All together against cancer
As a major player in the field of oncology in the Ile-de-France region, the Cancer Institute AP-HP. Nord – Université Paris Cité brings together the hemato-oncological care, research, and teaching activities of seven hospitals, all located in the north of Paris and making up the university hospital group AP-HP. Nord – Université Paris Cité, along with the Université Paris Cité.
The Cancer Institute AP-HP. Nord – Université Paris Cité pools the strengths of the Saint-Louis, Bichat – Claude-Bernard, Beaujon, Robert-Debré, Lariboisière, Louis-Mourier, and Bretonneau hospitals in all areas of oncology, developing reference activities in bone marrow transplantation, cell therapies (CAR-T), and early-phase clinical trials, in order to provide patients with the highest level of care and to achieve excellence in cancer research.
More than 150 physicians, 180 researchers, engineers and post-doctoral fellows are engaged in cancer treatment as well as basic and translational research activities.
Our missions, Our ambition
The objective of the Cancer Institute AP-HP. Nord – Université Paris Cité is to structure this network of hospitals into a single university hospital entity.
Dedicated to coordinated patient care and cancer research, with coherent and clear pathways offered to patients, the Institute promotes the pooling of knowledge, skills, and resources between the hospitals involved in cancer care, research, and teaching.
